AZN
AstraZeneca PLC
NYSE · usd
AstraZeneca PLC (AZN) trades at $170.89 (-0.97%) as of 9:53:28 AM EDT on Oct 23, 2026, +3.79% over the past month. Market cap is $267.64B, with 1.0 days to cover in short interest.
Stock performance
How AstraZeneca PLC (AZN) stock has performed from one day to one year, with its 52-week range.
- 1D
- -1.03%
- 1W
- +3.26%
- 1M
- +3.79%
- YTD
- -7.10%
- 1Y
- +2.53%
- 52-wk range
- $153.41 – $212.71
Key statistics
Today's trading snapshot for AZN: day range, open, previous close, volume and market cap.
- Day range
- $170.63 – $171.75
- Open
- $171.28
- Prev close
- $172.57
- Volume
- 348.8K
- Market cap
- $267.64B
- Shares out
- 1.55B
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for AstraZeneca PLC: P/E, P/S, P/B, ROE and more.
- P/E
- 120.50
- P/S
- 11.12
- P/B
- 19.78
- P/FCF
- 117.64
- ROE
- 16.4%
- ROA
- 3.5%
- Debt/Equity
- 1.40
- Div yield
- 1.32%
As of Oct 22, 2026
Dividend history and stock splits
AstraZeneca PLC's recent dividend payments and stock splits.
Dividends
- $0.80ex-div Aug 7, 2026
- $1.60ex-div Feb 20, 2026
- $0.52ex-div Aug 8, 2025
- $1.05ex-div Feb 21, 2025
Splits
- 1-for-2Feb 2, 2026
- 2-for-1Jul 27, 2015
AZN short interest
How heavily AZN is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 1.0
- Short interest
- 2.62M
- Avg volume
- 2.81M
As of · reported to FINRA twice monthly.
AZN news
The latest news and headlines about AstraZeneca PLC (AZN).
- AstraZeneca Gets Accelerated FDA Nod for Ultomiris in IgA NephropathypositiveZacks Investment Research· Oct 22, 2026
- Summit Expands Ivonescimab Development Into Biliary Tract CancerpositiveZacks Investment Research· Oct 22, 2026
- Global Oral Drugs Market is Predicted to Surpass USD 1 Trillion Mark by 2034 | DelveInsightpositiveGlobeNewswire Inc.· Oct 21, 2026
- Can Expanding Ivonescimab Development Unlock SMMT's Growth Potential?positiveZacks Investment Research· Oct 21, 2026
- Biotech ETF (BBH) Hits New 52-Week HighpositiveZacks Investment Research· Oct 21, 2026
Frequently asked questions
What is the AstraZeneca PLC (AZN) stock price today?
AstraZeneca PLC (AZN) is trading at $170.89 (-0.97% on the day) as of 9:53:28 AM EDT on Oct 23, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is AstraZeneca PLC?
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease…
What is the short interest in AZN?
As of Sep 30, 2026, AZN has 2.62M shares short and 1.0 days to cover.
Does AstraZeneca PLC (AZN) pay a dividend?
Yes. AstraZeneca PLC (AZN)'s most recent dividend was $0.80 per share, with an ex-dividend date of Aug 7, 2026. Full AZN dividend history is available from the Massive API.
What exchange is AZN listed on?
AstraZeneca PLC (AZN) trades on NYSE in USD.
Build with AI
Build an analysis of AZN with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a AZN analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.